A Comprehensive Summary of the Current Understanding of the Relationship between Severe Obesity, Metabolic Syndrome, and Inflammatory Status

• Published in: Journal of clinical medicine Vol. 12; no. 11; p. 3818
• Main Authors: Ion, Razvan-Marius, Sibianu, Melania, Hutanu, Adina, Beresescu, Felicia Gabriela, Sala, Daniela Tatiana, Flavius, Mocian, Rosca, Ancuta, Constantin, Calin, Scurtu, Alexandra, Moriczi, Renata, Muresan, Mircea Gabriel, Gabriel, Popescu, Niculescu, Raluca, Neagoe, Radu Mircea
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 02.06.2023; MDPI
• Subjects: Abdomen; Blood; Blood pressure; Body fat; Body mass index; Cancer; Cardiovascular disease; Cholesterol; Clinical medicine; Complications and side effects; Development and progression; Diabetes; Diagnosis; Energy consumption; Fatty acids; Females; Glucose; Inflammation; Insulin; Medical examination; Metabolic syndrome; Metabolic syndrome X; Morbidity; Mortality; Obesity; Overweight; Review; Risk factors; Triglycerides; Weight control; Romania; Europe; metabolic syndrome; morbid obesity; pro-inflammatory status; weight-loss effects
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12113818

At present, obesity, as a part of metabolic syndrome, represents the leading factor for disability, and is correlated with higher inflammation status, morbidity, and mortality. The purpose of our study is to add new insights to the present body of knowledge regarding the correlations between chronic systemic inflammation and severe obesity, which cannot be treated without considering other metabolic syndrome conditions. Biomarkers of high-level chronic inflammation are recognized as important predictors of pro-inflammatory disease. Besides the well-known pro-inflammatory cytokines, such as WBCs (white blood cells), IL-1 (interleukin-1), IL-6 (interleukin-6), TNF-alpha (tumor necrosis factor-alpha), and hsCRP (high-sensitivity C-reactive protein), as well as anti-inflammatory markers, such as adiponectin and systemic inflammation, can be determined by a variety of blood tests as a largely available and inexpensive inflammatory biomarker tool. A few parameters, such as the neutrophil-to-lymphocyte ratio; the level of cholesterol 25-hydroxylase, which is part of the macrophage-enriched metabolic network in adipose tissue; or levels of glutamine, an immune-metabolic regulator in white adipose tissue, are markers that link obesity to inflammation. Through this narrative review, we try to emphasize the influence of the weight-loss process in reducing obesity-related pro-inflammatory status and associated comorbidities. All data from the presented studies report positive results following weight-loss procedures while improving overall health, an effect that lasts over time, as far as the existing research data show.